4/A//SEC Filing
ACHILLION PHARMACEUTICALS INC 4/A
Accession 0001181431-14-038085
CIK 0001070336operating
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 1:24 PM ET
Size
5.7 KB
Accession
0001181431-14-038085
Insider Transaction Report
Form 4/AAmended
Apelian David
EVP and Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2014-12-02+175,000→ 175,000 totalExercise: $13.24Exp: 2024-12-02→ Common Stock (175,000 underlying)
Footnotes (2)
- [F1]Table II, column 5 of the Form 4 filed on December 4, 2014 (the "Original Form 4") inadvertently reported a disposition of options. This amendment is being filed solely to correct Table II, column 5 to show an acquisition of options. Except for the foregoing, no new or revised transactions or holdings are being reported by this amendment, and all other information reported in the Original Form 4 remains the same.
- [F2]This option grant vests as to 25% of the shares on the first anniversary of the date of grant and as to an additional 6.25% at the end of each three month period thereafter.
Documents
Issuer
ACHILLION PHARMACEUTICALS INC
CIK 0001070336
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001070336
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 1:24 PM ET
- Size
- 5.7 KB